FDA allows marketing of first device to prevent migraine headaches

On March 11, the U.S. Food and Drug Administration (FDA) allowed marketing of the first device as a preventative treatment for migraine headaches. This is also the first transcutaneous electrical nerve stimulation device specifically authorized for use before the onset of pain. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here